Prolia will be given by your health care provider every 6 months. It is a subcutaneous injection (given under the skin) that is administered in the upper arm, upper thigh, or abdomen.

Prolia is administered as a single subcutaneous injection of 60mg once every six months. For further information on Prolia, please visit: www.prolia.com. About Denosumab Collaborations ...

Prolia injection is a RANK ligand inhibitor, a regulator of osteoclasts. Prolia is already approved for the treatment of postmenopausal women with osteoporosis at high risk for fracture.

Denosumab is given by injection every 6 months and is approved for postmenopausal women who are at high risk for fracture or who cannot use another osteoporosis medicine or do not tolerate other ...

August 11, 2009 — Denosumab injections are associated with lower fracture rate in postmenopausal women with osteoporosis, according to the results of an international, randomized, double-blind ...

All 60 women who completed DATA-HD were invited to enroll in the extension, in which they received a single 5 mg dose of zoledronic acid by IV injection 24 to 35 weeks after their last denosumab dose.

Prolia, the first and only FDA-approved RANK Ligand inhibitor, is an every six month 60 mg subcutaneous injection administered by a health care professional.

Prolia, which is given by injection once every six months, works to decrease the destruction of bone and increase bone mass and strength by inhibiting proteins that activate bone-destroying cells.

Denosumab, an injection just under the skin given only twice a year, would have to compete against eight major types of pills and injected medicines, including estrogen and generic and brand-name ...

The bone density of vertebrae rose, on average, by 9.2 percent and hip bone density by 6 percent in women getting denosumab, whereas women in the placebo group showed no gains. Also, 2.3 percent ...

In the comparison of 1523 women on dialysis initiating denosumab (60 mg injection) and 1281 initiating oral bisphosphonates, severe hypocalcemia within 12 weeks occurred at a much higher rate in ...